Medpace Holdings

MEDPsupplier

Medpace is a differentiated full-service CRO focused exclusively on biotech clients (not Big Pharma), with a scientific-first model and 40+ year average clinician tenure driving industry-best quality.

⇄ Compare

Productos e Ingresos

Participación de Ingresos por Producto

Desglose de Ingresos ($2.30B)

Datos estáticos (cargando finanzas en tiempo real…)

Net Revenue (Services) (100%)

Composición de segmentos y clientes principales

Detalles del producto

Full-Service CRO85%

End-to-end clinical trial management for biotech clients — Phase I-IV, regulatory, data management, biometrics.

Regulatory Consulting15%

FDA/EMA regulatory strategy, IND/NDA writing, and submission preparation.

Relaciones en la Cadena de Suministro

Clientes Clave

Eli Lilly and Company

Phase II/III clinical trial management

Impacto: moderate

Moderna, Inc.

mRNA vaccine clinical services

Impacto: moderate

Contexto macro y de mercado

헬스케어Noticias del sector

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Próximos catalizadores

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Últimas noticias

Cargando noticias...

Análisis IA

Haz clic en "Obtener Análisis IA" para un análisis de cadena de suministro de Medpace Holdings impulsado por IA.

Información de la Empresa

Sede Central

Cincinnati, Ohio, USA

Fundación

1992

Empleados

5,800

Sitio Web

medpace.com

Estado del sector — 헬스케어

Noticias del sector